New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
04:55 EDTCGIX, CGIX, CGIX, HART, HART, HART, NURO, NURO, NURO, CANF, CANF, CANF, AMBS, AMBS, AMBS, AGEN, AGEN, AGEN, AVXL, AVXL, AVXL, SYN, SYN, SYN, CEMI, CEMI, CEMI, SRNE, SRNE, SRNE, OXBT, OXBT, OXBTOneMedPlace to hold a forum
7th Annual OneMedForum SF 2014 is being held in San Francisco on January 13-15.
News For CGIX;SRNE;CEMI;SYN;AVXL;AGEN;AMBS;CANF;NURO;HART;OXBT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
06:59 EDTSYNSynthetic Biologics granted patent for C. difficile
Synthetic Biologics has been issued a Notice of Allowance by the USPTO for a composition of matter patent application that covers the lead product in its C. difficile program, SYN-004. This is Synthetic Biologics' first allowed patent application directly pertaining to SYN-004 in the U.S. SYN-004 is Synthetic Biologics' novel oral enzyme drug candidate designed as the first and only prophylactic treatment intended to prevent the development of C. difficile infections.
October 21, 2014
08:09 EDTCGIXCancer Genetics granted patent for FHACT
Subscribe for More Information
October 20, 2014
17:18 EDTSYNGreat Point Partners reports 9.98% passive stake in Synthetic Biologics
Subscribe for More Information
October 17, 2014
11:47 EDTCANFCan-Fite BioPharma management to meet with Roth Capital
Subscribe for More Information
08:31 EDTHARTHarvard Apparatus says patient in transplant study passes away
Subscribe for More Information
October 15, 2014
16:47 EDTNURONeuroMetrix files to sell 3.3M shares of common stock for holders
Subscribe for More Information
07:32 EDTCGIXRedChip Companies to hold a virtual conference
Subscribe for More Information
October 14, 2014
16:04 EDTSRNESorrento Therapeutics announces positive results from pharmacokinetic data
Subscribe for More Information
October 13, 2014
07:52 EDTCGIXCancer Genetics partners with Columbia University oncology researchers
Cancer Genetics has entered into a research collaboration with Columbia University's Azra Raza, MD, director of the MDS Center and assistant professor of medicine at Columbia University Medical Center, and Siddhartha Mukherjee, MD, PhD, assistant professor of medicine at CUMC, to identify more accurate diagnostic and prognostic markers for myelodysplastic syndromes, as well as novel therapies to target this class of bone marrow cancers. The ultimate goal of the collaboration is to develop personalized therapy for MDS patients and to enable accurate prediction of future treatment needs before patients become resistant to their current therapy or before their MDS progresses to the more aggressive acute myeloid leukemia.
October 10, 2014
16:18 EDTAGENAgenus files $150M mixed securities shelf
08:57 EDTSYNSynthetic Biologics raises $20.7M in a registered direct offering
Subscribe for More Information
October 9, 2014
06:05 EDTAMBSAmarantus Bioscience's Alzheime blood test shows positivie results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use